Autres langues Milestone Scientific Inc.

Actions

MLSS

US59935P2092

Equipement et technologie médicale avancés

Marché Fermé - NYSE 22:00:00 02/10/2026			Varia. 5j.	Varia. 1 janv.
0,3780 ^USD	-7,58%		-7,96%	+38,46%

29/09	Milestone Scientific Inc. souligne les progrès continus réalisés dans la mise en place d’une plateforme de croissance structurée et évolutive pour son activité médicale CompuFlo	CI
14/08	Transcript : Milestone Scientific Inc., Q2 2026 Earnings Call, Aug 14, 2026

Autres langues

29/09	Milestone Scientific Inc. Highlights Continued Progress in Building A Structured and Scalable Growth Platform for Its Compuflo Medical Business
29/09	Milestone Scientific Highlights Building a Scalable Growth Platform for CompuFlo® Medical Business
16/09	Milestone Scientific Announces Pain and Spine Specialists and Dr. Sudhir Rao as CompuFlo® Development Partner and Advisor
26/08	Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors
14/08	Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026
14/08	Milestone Scientific Reports Financial Results for Second Quarter 2026
13/08	Milestone Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08	Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
04/08	Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
04/08	Milestone Scientific Inc. Announces Federal Distribution Agreement with Red One Medical
31/07	Milestone Scientific Inc. Ratifies Appointment of Grassi & Co. Certified Public Accountants, Pc as Independent Auditors
15/07	Milestone Scientific Launches First Phase of Ai Strategy with Pilot Debut of Milo Ai-Enabled Digital Engagement Platform At Aspn 2026
15/07	Milestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Platform, at ASPN 2026
01/07	Milestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
01/07	Milestone Scientific Inc. Provides Earnings Guidance for the Second Quarter and Six Months Ended June 30, 2026
25/06	Milestone Scientific Inc. Announces Board and Committee Changes
25/06	Milestone Scientific Strengthens Board to Support Next Phase of Growth
27/05	Milestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Epidural, Neuromodulation, and Interventional Pain Procedures
27/05	Milestone Scientific Highlights Growing Clinical Adoption And Expanding Physician Acceptance Of CompuFlo Epidural System Across Epidural, Neuromodulation, And Interventional Pain Procedures
14/05	Milestone Scientific Reports Financial Results for First Quarter 2026
14/05	Milestone Scientific Inc. Reaffirms Earnings Guidance for the Year Ending December 31, 2026
13/05	Milestone Scientific Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
08/05	Milestone Scientific Expands CompuFlo Medical Business with Advisor Program and Growing National Clinical Adoption
07/05	Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call
07/05	Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption